Patient Monitoring Devices Market Size, Share and Trend Analysis, By Product Type (Blood glucose monitoring, Cardiac Monitoring Device, Respiratory monitoring device, Neuro monitoring device, and Others), By Application (Cardiology, Neurology, Respiratory, Fetal and Neonatal, Others), and By End-Use, and By Region, Forecast 2025-2032

Patient Monitoring Devices Market Overview and Key Insights:

The global patient monitoring devices market size reached USD 48.3 billion in 2024 and is expected to register a revenue CAGR of 8.8% during the forecast period. Rising prevalence of chronic diseases, growing adoption of remote patient monitoring, and increasing demand for personalized healthcare solutions are key factors driving revenue growth in the patient monitoring devices market.

Market Drivers:

Chronic disease or non-communicable diseases (NCDs) worldwide are increasing owing to factors such as rapid urbanization, changes in lifestyle, and lack of physical activity. According to the World Health Organization (WHO), each year around 43 million individuals lose their lives due to noncommunicable diseases (NCDs), accounting for 75% of total global deaths.

Advancement of hospital and home healthcare is significantly accelerating adoption of patient monitoring devices. Healthcare organizations are progressively shifting from dependence on hospital-based care and periodic checkups to remote patient health monitoring. As a result, a substantial number of healthcare organizations are extending patient care services with the help of patient monitoring devices.

Moreover, surging demand for patient monitoring devices for geriatric patients is an emerging market trend. According to the World Health Organization (WHO), 1 in 6 people in the world will be aged over 60 years by 2030. The patient monitoring devices have potential to enhance quality of care for geriatric patients and allow the doctor to diagnose the patient’s conditions effectively. As a result, these factors are pioneering new revenue streams and are expected to contribute significant market revenue share over the forecast period.

Market Opportunity:

Prominent players across the patient monitoring devices market are receiving regulatory approval from the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), Pharmaceutical and Medical Device Agency (PMDA which are further propelling opportunities of the market. For instance, in October 2024, Japan’s Pharmaceutical and Medical Device Agency (PMDA) granted approval to iRhythm Technologies Inc. for its Zio 14-day continuous ECG monitoring system.

The Zio long-term continuous monitoring (LTCM) solution includes a prescription-only patch-based ECG device (Zio monitor) that can be worn for up to 14 days. In addition, in October 2023, InfoBionic received FDA 510(k) clearance for an AI-enabled remote ECG monitoring device. In addition, Sleepiz AG received FDA 510(k) clearance for a contactless remote patient monitoring device.

Technological Trends:

Recent progress in innovative new product developments and incorporation of artificial intelligence (AI) and machine learning (ML) algorithm-based patient monitoring devices are generating future revenue expansion scopes. Al and ML-based devices detect potential health risks by monitoring and tracking critical health attributes such as ECG, blood glucose, blood pressure, and various other risk factors. Several companies are working on the development and commercial availability of AI/ML-based patient monitoring devices.

BD introduced a new monitoring platform in April 2025 that incorporates AI-driven tools designed to anticipate potentially dangerous shifts in a patient’s blood pressure during critical medical procedures. Also, in February 2025, Validid introduced a patent-pending digital remote patient monitoring (RPM) assistant designed to enhance clinical decision-making. The solution leverages Generative AI (GenAI) to interpret and summarize patient data trends. It also provides faster and more comprehensive insights into patient health.

Restraints & Challenges:

High-cost association with patient monitoring devices is a major factor restraining the market revenue growth. Primary healthcare costs in low-and middle-income countries are increasing; as a result, consumers avoid making purchases of patient monitoring devices. Also, non-communicable diseases (NCDs) cases are significantly high in low- and middle-income countries. According to the World Health Organization (WHO), 77% NCD deaths are in low- and middle-income countries.

In addition, stringent regulatory compliance by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) is slowing down the adoption rate of patient monitoring devices. Companies must undergo rigorous testing and provide extensive testing documentation in compliance with the strict guidelines of the regulatory bodies. These critical factors may delay product launch, which effectively impacts product development cost.

Product Type Segment Insights and Analysis:

Based on the product type, the patient monitoring devices market is segmented into blood glucose monitoring, cardiac monitoring devices, respiratory monitoring devices, neuro monitoring devices, hemodynamic monitoring devices, and others.

The blood glucose segment accounts for a significant revenue share in 2024. Widespread adoption of blood glucose monitoring devices owing rising prevalence of blood sugar is a primary factor in the largest market revenue contribution. According to the World Health Organization (WHO), around 830 million people worldwide have diabetes in 2022, around 2 million deaths are registered due to diabetes.

Substantial growth in innovative non-invasive blood glucose monitoring devices is expected to generate steady revenue over the forecast period.  For instance, in November 2023, Synex Medical a Canada-based biotech firm can developed a monitoring device that can check the blood sugar level without even a drop of blood.

Rapid advancement in continuous glucose monitoring has evolved significantly with the integration of various monitoring devices, including insulin pumps, connected insulin pens (CIPs), and automated insulin delivery (AID). This advancement will further enhance the market revenue growth.

Cardiac monitoring device segment registered the fastest CAGR over the forecast period. Rising prevalence of cardiovascular diseases (CVDs) is attributed to the growth rate. According to the WHO, Cardiovascular diseases (CVDs) account for 17.9 million deaths each year.

Application Segment Insights and Analysis:

Based on the application, the patient monitoring devices market is segmented into Cardiology, Neurology, Respiratory, Fetal and Neonatal, and Others.

The cardiology accounts for the largest revenue share in 2024. The escalating prevalence of cardiovascular diseases and the need for constant patient monitoring systems across hospitals and ambulatory settings are some of the key contributors to the patient monitoring devices market. These devices, dedicatedly used in cardiology, e.g., ECG monitors, heart rate monitors, and implantable cardiac devices, are indispensable in early diagnosis, risk management. Also, the ongoing wearables and less invasive cardiac monitoring solution industries’ innovation are supporting growth of the market.

Prominent key player in patient monitoring devices market, GE HealthCare, receives the U.S. Food and Drug Administration (FDA) clearance for Portrait mobile. The Portrait Mobile wearable, wireless continuous monitoring solution from GE HealthCare gives a real-time personalised view of the patient and stimulates movement while continually monitoring dual vector respiration rate, SpO2, and pulse rate.

Emerging market trends of wearable biosensors and insertable cardiac monitors are further projected to accelerate market revenue expansion. For instance, in October 2023, Boston Scientific launched insertable cardiac monitors for the detection of cryptogenic stroke, syncope, and other potential risks associated with CVDs. These innovations allow continuous, remote, and precise cardiac monitoring, addressing unmet clinical needs and further solidifying cardiology as the leading application segment in patient monitoring devices globally.

End-Use Segment Insights and Analysis:

Based on the End-Use, the Patient Monitoring Devices Market is consumer Hospitals, Ambulatory services, home care settings, and others.

Hospital segment is accounted for the largest revenue share in 2024. Hospitals have a variety of monitoring devices to track patients’ health. Monitoring devices record important parameters to assess the patient’s condition, such as the patient’s body temperature, blood pressure, blood oxygen saturation level, heart rate, and rhythm.

Ambulatory services segment registered the fastest CAGR over the forecast period. Ambulance services are equipped with various monitoring devices as well, such as a heartbeat sensor, a temperature sensor ECG, and an SPO2 level tracker. Ambulatory services provide a more cost-effective option for a range of treatments and procedures when compared with inpatient care.

Geographical Outlook:

The Patient Monitoring Devices Market is strategically segmented by geography to provide a comprehensive understanding of regional market dynamics. Discover demand analysis, emerging trends, and growth opportunities shaping market performance across different regions and countries.

North America Patient Monitoring Devices Market:

North America registered the largest market share in the patient monitoring devices market. According to the Centers for Disease Control and Prevention (CDC) of the U.S., 6 out of 10 Americans have one chronic disease, such as heart disease, stroke, cancer, or diabetes, which lead to death and disability in the people of the United States. Patient monitoring devices are increasingly being adopted for disease prevention and monitoring treatments in hospitals and homes.

Healthcare spending is another major correlating factor in the revenue expansion of patient monitoring devices in North America. According to the American Medical Association (AMA), healthcare spending in the U.S. was around USD 14,570 per capita in 2025. Also, the rapid rate of regulatory clearance by the U.S. Food and Drug Administration (FDA) is driving new innovations in market.

For instance, in July 2023, FIRE 1 launched a new heart failure device and tested it on a US patient to track fluid levels in the body that cause congestive heart failure. This innovation can give a significant boost in the market as cardiovascular diseases is the leading cause of death in the United States. According to the Centers for Disease Control and Prevention, 919,032 people died from cardiovascular disease in 2023.

Moreover, market for patient monitoring devices is growing exponentially owing to increasing prevalence of chronic diseases in Canada. According to Statistics Canada, 89% of the deaths are related to chronic diseases, and more than USD 80 billion is spent annually on health care costs. These factors are enhancing consumer adoption of patient monitoring devices in Canada.

Asia Pacific Patient Monitoring Devices Market:

The Asia-Pacific region holds the largest revenue share in 2024 and is projected to achieve a CAGR of 13.4% by 2032. Increasing prevalence of cardiovascular diseases (CVD), diabetes, cancer, and chronic respiratory diseases across countries in the Asia Pacific is a major factor accelerating market revenue expansion.

The spread of transmissible health threats such as influenza, dengue, and pneumonia are predicted to accelerate the usage of patient monitoring devices. According to the United Nations International Children’s Emergency Fund (UNICEF), every year, there are around 1,400 cases of pneumonia per 100,000 children, or 1 case per 71 children, with South Asia holding the highest rate.

Moreover, the government production-linked incentive (PLI) system has further incentivized local medical device manufacture, which is generating several opportunities in the future market expansion. For instance, in April 2023, the Government of India approved the National Medical Devices Policy, 2023. A total of 26 projects have been approved under the PLI scheme for Medical Devices, with an investment commitment of USD 147 Mn and a total investment of USD 87 Mn.

Europe Patient Monitoring Devices Market:

Europe accounts for substantial revenue share in 2024. Increasing adoption of patient monitoring devices to reduce risk associated with cardiovascular diseases (CVD) is driving fastest market revenue expansion growth in Europe. According to the European Society of Cardiology (ESC), each year CVD causes around 3.9 million deaths in Europe.

Rapid technological development and new innovations are further contributing to the market revenue growth in Europe. For instance, in June 2023, AliveCor collaborated with Luscii for the development of Luscii Virtual Heart Clinic. This app will help cardiologist to gather comprehensive vital signals of their patients remotely.

Additionally, growing focus on remote patient monitoring for geriatric patients is expected to support market revenue expansion over the forecast period. According to the European Commission (EC), more than one-fifth, which is about 21.6% of the EU population, was aged 65 and over. Key competitors are targeting in-home patient treatment, another major trend for future revenue generation stream in Europe.

Competition Analysis:

The Patient Monitoring Devices Market is characterized by numerous players, with major players competing across segments and regions. The list of major players included in the Patient Monitoring Devices Market report is:

• Siemens Healthineers AG
• GE HealthCare
• Koninklijke Philips N.V.
• Medtronic
• Smith+Nephew
• Smith’s Group plc
• Baxter
• OMRON Corporation
• ZOLL Medical Corporation
• Becton, Dickinson and Company
• Abbott
• Johnson & Johnson, Inc
• Masimo
• Boston Scientific Corporation
• Health Anywhere Inc.
• Biotronik
• Welch Allyn
• Sleepiz AG
• Validic Inc. 
• Cardinal Health

Strategic Developments in the Patient Monitoring Devices Market:

• On 16^th September 2025, Baxter International Inc. introduced the Welch Allyn Connex 360 Vital Signs Monitor, a next-generation solution aimed at enhancing patient monitoring in hospital settings. The device is designed to improve workflow efficiency and strengthen data security, enabling healthcare providers to capture vital signs accurately across a wide range of patient populations. The FDA-approved monitor integrates seamlessly with electronic medical record (EMR) systems, minimizing the risk of manual data entry errors and ensuring clinicians have access to timely, reliable information.
• On 4^th June 2025, Cardinal Health launched its new multi-parameter, single-patient use monitoring cable and lead wire system in the U.S., designed to streamline patient monitoring by consolidating cardiac activity, oxygen saturation, and temperature tracking into a single connection. The product is known as the Kendall DL Multi System. The system is engineered to enhance clinical workflows, deliver reliable real-time data to guide treatment decisions, and improve overall hospital efficiency.

Key Advantages for Stakeholders:

Navistrat Analytics’ industry report provides an in-depth quantitative analysis of various market segments, historical and current trends, market forecasts, and dynamics within the global market. The historical years covered in this report are 2022 to 2023, with 2024 serving as the base year for market size calculations. The forecast period extends from 2025 to 2032.

The report includes an executive summary and a comprehensive overview of market drivers, restraints, opportunities, and challenges (DROC), along with insights into regulatory standards. It features detailed analyses such as PORTER’s Five Forces, SWOT, and PESTLE, as well as assessments of technological trends and the competitive landscape.

PORTER’s Five Forces analysis helps stakeholders evaluate the impact of new entrants, competitive rivalry, supplier power, buyer power, and substitution threats, enabling them to assess the level of competition and the attractiveness of the global market. The competitive landscape provides stakeholders with a clear understanding of the current market positions of key players, offering valuable insights into their competitive environment.

Scope And Key Highlights of The Patient Monitoring Devices Market Report:

The patient monitoring devices market report offers a detailed analysis of market size, including historical revenue (in USD Billion) data for 2022-2023 and revenue forecasts for 2025-2032 across the following segments:

• Product Type Outlook (Revenue, USD Billion; 2022-2032)
  • Blood glucose monitoring
    • Self-monitoring glucose system
    • Continuous monitoring system
  • Cardiac Monitoring Device
    • ECG Devices
    • Implantable loop recorders
    • Event Monitors
    • MCT Monitors
    • SMART wearable ECG bands
  • Respiratory monitoring device
    • Pulse Oximeters
    • Spirometer
    • Capnographs
    • Peak Flow meters
  • Neuro monitoring device
    • Electroencephalograph Machines
    • Electromyography Machines
    • Cerebral Oximeters
    • Intracranial Pressure monitors
    • Transcranial Doppler Machines
  • Hemodynamic monitoring device
    • Hemodynamic Monitoring Devices
    • Blood Pressure Monitors
    • Disposable
  • Others

• Application Outlook (Revenue, USD Billion; 2022-2032)
  • Cardiology
  • Neurology
  • Respiratory
  • Fetal and Neonatal
  • Others

• End-Use Outlook (Revenue, USD Billion; 2022-2032)
  • Hospitals
  • Ambulatory services
  • Home care settings
  • Others

• Regional Outlook (Revenue, USD Billion; 2022-2032)
  • North America
    1. U.S.
    2. Canada
    3. Mexico
  • Europe
    1. Germany
    2. France
    3. U.K.
    4. Italy
    5. Spain
    6. Benelux
    7. Nordic Countries
    8. Rest of Europe
  • Asia Pacific
    1. China
    2. India
    3. Japan
    4. South Korea
    5. Taiwan
    6. Oceania
    7. ASEAN Countries
    8. Rest of APAC
  • Latin America
    1. Brazil
    2. Rest of LATAM
  • Middle East & Africa
    1. GCC Countries
    2. South Africa
    3. Israel
    4. Turkey
    5. Rest of MEA

Frequently Asked Questions (FAQ) About the Patient Monitoring Devices Market Report